Skip to main content

Fibrotic

Fibrotic

Biotherapeutic for Systemic Sclerosis

Epiregulin Inhibition to Treat Scleroderma Skin and Lung Fibrosis

Targeting Profibrotic Macrophages Using Mir-33 Inhibitors, a Novel Therapeutic Approach for Pulmonary Fibrosis

Allagium Therapeutics: Driving Change to Better Health

Drugcode Biotech: The Next Generation of Drug Prediction Platforms

Endothelial-Cell Specific Wnt Inhibition: Novel Therapy for Renal Fibrosis

Thyron Pharmaceuticals: Thyroid Hormone Mimetics for Reversal of Lung Injury and Fibrosis

Subscribe to Fibrotic